Evidence map›Paper›PMID 38975928›Full record

ArticleAnalytical chemistry2024

Sample-to-Answer Detection of SARS-CoV-2 Viremia Using Thermally Responsive Alkane Partitions.

David J Boegner, Miso Na, Anthony D Harris, Robert H Christenson, Colleen M Damcott, Brent King, LaToya Stubbs, Peter Rock, Ian M White

Abstract read
In one paragraph

Article in Analytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

David J BoegnerFischell Department of Bioengineering, University of Maryland, College Park, Maryland 20742, United States.ORCID 0000-0002-8900-5208
Miso NaFischell Department of Bioengineering, University of Maryland, College Park, Maryland 20742, United States.
Anthony D HarrisDepartment of Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, Maryland 21201, United States.
Robert H ChristensonDepartment of Pathology, The University of Maryland School of Medicine, Baltimore, Maryland 21201, United States.
Colleen M DamcottDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21201, United States.
Brent KingDepartment of Emergency Medicine, The University of Maryland School of Medicine, Baltimore, Maryland 21201, United States.
LaToya StubbsDepartment of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, United States.
Peter RockDepartment of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, United States.
Ian M WhiteFischell Department of Bioengineering, University of Maryland, College Park, Maryland 20742, United States.ORCID 0000-0003-4426-9311

Funding

Enabling exosome biomarker development via digitized single vesicle analysisR01GM130923 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI DEVOE, DON L, WHITE, IAN M · 2019 to 2022
$1.7M
Point-of-care magnetofluidic HCV diagnostic using thermally responsive valvesR01AI176197 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI Ian M White · 2024 to 2026
$1.2M
NIAID NIH HHS R01 AI176197NIGMS NIH HHS R01 GM130923
6 · The paper itself

Abstract

The diagnosis of bloodborne viral infections (viremia) is currently relegated to central laboratories because of the complex procedures required to detect viruses in blood samples. The development of point-of-care diagnostics for viremia would enable patients to receive a diagnosis and begin treatment immediately instead of waiting days for results. Point-of-care systems for viremia have been limited by the challenges of integrating multiple precise steps into a fully automated (i.e., sample-to-answer), compact, low-cost system. We recently reported the development of thermally responsive alkane partitions (TRAPs), which enable the complete automation of diagnostic assays with complex samples. Here we report the use of TRAPs for the sample-to-answer detection of viruses in blood using a low-cost portable device and easily manufacturable cassettes. Specifically, we demonstrate the detection of SARS-CoV-2 in spiked blood samples, and we show that our system detects viremia in COVID-19 patient samples with good agreement to conventional RT-qPCR. We anticipate that our sample-to-answer system can be used to rapidly diagnose SARS-CoV-2 viremia at the point of care, leading to better health outcomes for patients with severe COVID-19 disease, and that our system can be applied to the diagnosis of other life-threatening bloodborne viral diseases, including Hepatitis C and HIV.

Indexed as

AlkanesCOVID-19SARS-CoV-2ViremiaHumansPoint-of-Care SystemsRNA, ViralTemperatureAlkanesRNA, Viral

Identifiers

PMID38975928
PMCPMC11724521

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.